- Home
- RIME vs AIMD Comparison
RIME vs AIMD Comparison
Compare RIME & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIME
- AIMD
- Stock Information
- Founded
- RIME 1982
- AIMD 1984
- Country
- RIME United States
- AIMD United States
- Employees
- RIME N/A
- AIMD N/A
- Industry
- RIME
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- RIME
- AIMD Health Care
- Exchange
- RIME NYSE
- AIMD Nasdaq
- Market Cap
- RIME 4.9M
- AIMD 5.2M
- IPO Year
- RIME 1994
- AIMD N/A
- Fundamental
- Price
- RIME $0.23
- AIMD $0.44
- Analyst Decision
- RIME
- AIMD
- Analyst Count
- RIME 0
- AIMD 0
- Target Price
- RIME N/A
- AIMD N/A
- AVG Volume (30 Days)
- RIME 790.7K
- AIMD 255.7K
- Earning Date
- RIME 11-26-2024
- AIMD 11-06-2024
- Dividend Yield
- RIME N/A
- AIMD N/A
- EPS Growth
- RIME N/A
- AIMD N/A
- EPS
- RIME N/A
- AIMD N/A
- Revenue
- RIME $37,788,657.00
- AIMD $40,633.00
- Revenue This Year
- RIME N/A
- AIMD N/A
- Revenue Next Year
- RIME N/A
- AIMD N/A
- P/E Ratio
- RIME N/A
- AIMD N/A
- Revenue Growth
- RIME 24.99
- AIMD N/A
- 52 Week Low
- RIME $0.22
- AIMD $0.40
- 52 Week High
- RIME $1.97
- AIMD $4.29
- Technical
- Relative Strength Index (RSI)
- RIME N/A
- AIMD 38.69
- Support Level
- RIME N/A
- AIMD $0.44
- Resistance Level
- RIME N/A
- AIMD $0.52
- Average True Range (ATR)
- RIME 0.00
- AIMD 0.05
- MACD
- RIME 0.00
- AIMD -0.00
- Stochastic Oscillator
- RIME 0.00
- AIMD 26.90
About RIME ALGORHYTHM HOLDINGS INC
Algorhythm Holdings Inc is a holding company with two primary investments. It operates through its subsidiaries, one of which is an emerging leader in the AI-enabled global logistics industry. The other subsidiary is engaged in consumer karaoke products, Which designs and distributes the industry's widest assortment of at-home and in-car karaoke entertainment products.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.